Biomarkers Market

The global boomers market is expected to grow at a CARR of 18. 5% from 2013 to 2018, to reach $40. 8 billion by 2018. Mimics technology including, proteomics, genomics, transcription’s, and metabolisms, is the largest segment of the global boomers discovery technology market. Advancement in discovery technologies such as genome sequencing is the prime factor contributing to the growth of this market. The discovery and development of boomers is costly and is a highly time consuming procedure.

Application of boomers in drug discovery and development educes the overall cost of the entire drug development process; hence, demand for novel boomers is expected to increase in the next five years. Discovery and development of potent boomers require thorough technological knowledge and expertise. Thus, in order to get access to highly sophisticated technologies and to divide the cost burden, partnerships and collaborations is the major strategy followed by market players. Companies such as Ruche Diagnostics Limited (Switzerland), Johnson & Johnson (U. S. , Siemens Healthcare (Germany), Abbott Laboratories, Inc. U. S. ), and Bio-Radar Laboratories, Inc. (U. S. ) are actively adopting the strategy of partnerships and collaborations, to ensure their growth in the boomers market. From an insight perspective, this research report has focused on various levels of analysis which includes company profiles (comprises and discusses the views on Boomers Market worth $40. 8 Billion by 2018 By marketer’s market, emerging discovery technologies, high growth regions and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The above mentioned market research data, current market size, and forecast of future trends will help the existing players and new entrants to make necessary decisions regarding product offerings, geographic focus, strategic approach,